81 FR 15307 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 55 (March 22, 2016)

Page Range		15307-15307
FR Document		2016-06352

Federal Register, Volume 81 Issue 55 (Tuesday, March 22, 2016)

[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Page 15307]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-06352]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
GH16-005, Operations Research (Implementation Science) for 
Strengthening Program Implementation through the Presidents Emergency 
Plan for AIDS Relief (PEPFAR).

Times and Dates

    9:00 a.m.-2:00 p.m., EDT, Panel 1, April 20, 2016 (Closed).
    9:00 a.m.-2:00 p.m., EDT, Panel 2, April 26, 2016 (Closed).
    9:00 a.m.-2:00 p.m., EDT, Panel 3, April 27, 2016 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Operations Research (Implementation Science) for Strengthening 
Program Implementation through the Presidents Emergency Plan for AIDS 
Relief (PEPFAR)'', FOA GH16-005.
    Contact Person for More Information: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-06352 Filed 3-21-16; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices 15307

review of applications in response to Times and Date: 8:30 a.m.–5:00 p.m., Times and Dates
Special Interest Project (SIP) 16–005, EDT, April 20–21, 2016 (Closed). 9:00 a.m.–2:00 p.m., EDT, Panel 1,
Multi-Level Communication Strategies Place: The Georgian Terrace, 659 April 20, 2016 (Closed).
to Promote Human Papilloma Virus Peachtree Street NE., Atlanta, GA 30308. 9:00 a.m.–2:00 p.m., EDT, Panel 2,
(HPV) Vaccination Uptake. April 26, 2016 (Closed).
Time and Date: 10:00 a.m.–6:00 p.m., Status: The meeting will be closed to
the public in accordance with 9:00 a.m.–2:00 p.m., EDT, Panel 3,
EDT, April 19, 2016 (Closed). April 27, 2016 (Closed).
provisions set forth in Section
Place: Teleconference. Place: Teleconference.
552b(c)(4) and (6), Title 5 U.S.C., and
Status: The meeting will be closed to the Determination of the Director, Status: The meeting will be closed to
the public in accordance with the public in accordance with
Management Analysis and Services
provisions set forth in Section provisions set forth in section 552b(c)
Office, CDC, pursuant to Public Law 92–
552b(c)(4) and (6), Title 5 U.S.C., and (4) and (6), title 5 U.S.C., and the
463.
the Determination of the Director, Determination of the Director,
Management Analysis and Services Matters for Discussion: The meeting Management Analysis and Services
Office, CDC, pursuant to Public Law 92– will include the initial review, Office, CDC, pursuant to Public Law 92–
463. discussion, and evaluation of 463.
Matters for Discussion: The meeting applications received in response to Matters for Discussion: The meeting
will include the initial review, ‘‘The CDC National Centers for will include the initial review,
discussion, and evaluation of Excellence in Youth Violence discussion, and evaluation of
applications received in response to Prevention: Building the Evidence for applications received in response to
‘‘Multi-Level Communication Strategies Community- and Policy-Level ‘‘Operations Research (Implementation
to Promote Human Papilloma Virus Prevention’’, RFA–CE–15–002. Science) for Strengthening Program
(HPV) Vaccination Uptake’’, SIP 16–005. Contact Person for More Information: Implementation through the Presidents
Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Emergency Plan for AIDS Relief
Jaya Raman Ph.D., Scientific Review Review Officer, CDC, 4770 Buford (PEPFAR)’’, FOA GH16–005.
Officer, CDC, 4770 Buford Highway, Highway, NE., Mailstop F–80, Atlanta, Contact Person for More Information:
Mailstop F80, Atlanta, Georgia 30341, Georgia 30341, Telephone: (770) 488– Hylan Shoob, Scientific Review Officer,
Telephone: (770) 488–6511, kva5@ 3585, email: EEO6@cdc.gov. Center for Global Health (CGH) Science
cdc.gov. The Director, Management Analysis Office, CGH, CDC, 1600 Clifton Road
The Director, Management Analysis and Services Office, has been delegated NE., Mailstop D–69, Atlanta, Georgia
and Services Office, has been delegated the authority to sign Federal Register 30033, Telephone: (404) 639–4796.
the authority to sign Federal Register notices pertaining to announcements of The Director, Management Analysis
notices pertaining to announcements of meetings and other committee and Services Office, has been delegated
meetings and other committee management activities, for both the the authority to sign Federal Register
management activities, for both the Centers for Disease Control and notices pertaining to announcements of
Centers for Disease Control and Prevention and the Agency for Toxic meetings and other committee
Prevention and the Agency for Toxic Substances and Disease Registry. management activities, for both the
Substances and Disease Registry. Centers for Disease Control and
Claudette Grant, Prevention and the Agency for Toxic
Claudette Grant,
Acting Director, Management Analysis and Substances and Disease Registry.
Acting Director, Management Analysis and Services Office, Centers for Disease Control
Services Office, Centers for Disease Control and Prevention. Claudette Grant,
and Prevention. Acting Director, Management Analysis and
[FR Doc. 2016–06350 Filed 3–21–16; 8:45 am]
[FR Doc. 2016–06349 Filed 3–21–16; 8:45 am] Services Office, Centers for Disease Control
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P and Prevention.
[FR Doc. 2016–06352 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
HUMAN SERVICES HUMAN SERVICES

Centers for Disease Control and DEPARTMENT OF HEALTH AND
Centers for Disease Control and HUMAN SERVICES
Prevention Prevention
Centers for Disease Control and
Disease, Disability, and Injury Disease, Disability, and Injury
Prevention
Prevention and Control Special Prevention and Control Special
Emphasis Panel (SEP): Initial Review Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury
Prevention and Control Special
In accordance with Section 10(a)(2) of In accordance with section 10(a)(2) of Emphasis Panel (SEP): Initial Review
the Federal Advisory Committee Act the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease (Pub. L. 92–463), the Centers for Disease In accordance with section 10(a)(2) of
Control and Prevention (CDC) Control and Prevention (CDC) the Federal Advisory Committee Act
asabaliauskas on DSK3SPTVN1PROD with NOTICES

announces a meeting for the initial announces a meeting for the initial (Pub. L. 92–463), the Centers for Disease
review of applications in response to review of applications in response to Control and Prevention (CDC)
Funding Opportunity Announcement Funding Opportunity Announcement announces a meeting for the initial
(FOA), RFA–CE–15–002, The CDC (FOA) GH16–005, Operations Research review of applications in response to
National Centers for Excellence in (Implementation Science) for Funding Opportunity Announcement
Youth Violence Prevention: Building Strengthening Program Implementation (FOA) DP 16–005, Study to Assess the
the Evidence for Community- and through the Presidents Emergency Plan Incidence of Type 1 Diabetes in Young
Policy-Level Prevention. for AIDS Relief (PEPFAR). Adults.

VerDate Sep<11>2014 19:01 Mar 21, 2016 Jkt 238001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\22MRN1.SGM 22MRN1

Document Created: 2018-02-02 15:15:59
Document Modified: 2018-02-02 15:15:59

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		81 FR 15307

81 FR 15307 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 81, Issue 55 (March 22, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention